ALMS
AlumisANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
ALMS vs peer average
78/100
ALMS vs. peer average (A vs. C)
Grade spread
B 4 · C 4 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
ARQT is the first available peer comparator.
A closer dermatology-biotech comp with more commercial footing; useful for framing how psoriasis-focused assets can trade once clinical validation starts to translate into launch execution.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ALMS
Alumis
ARQT
Arcutis Biotherapeutics
Grade
A
C
Momentum
46
18
Value
42
41
Sentiment
100
97
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs ARQT
ALMS / ARQT
Grade Position
Above peers
ALMS vs. peer average (A vs. C)
78/100
Momentum
46
ALMSValue
42
ALMSSentiment
100
ALMSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ALMS
ARQT is the first peer returned for this comparison set.